Bringing a humanistic approach to cancer clinical trials

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
CANCER INTELLIGENCE LTD
Citação
ECANCERMEDICALSCIENCE, v.11, article ID 738, 7p, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In this article, we describe some practical aspects that promote the humanisation of clinical research. Actions are not limited to improving the communication skills of medical staff but also include maintenance of care continuity, accessible written information, and application of theoretic models such as shared decision-making and management of stress in decision-making under uncertainty. We believe that a comprehensive strategy will increase patients' motivation to participate in and adhere to clinical research.
Palavras-chave
humanization, cancer, clinical trials
Referências
  1. Arai RJ, 2010, LANCET ONCOL, V11, P712, DOI 10.1016/S1470-2045(10)70168-6
  2. Bae JM, 2015, EPIDEMIOL HLTH, V37
  3. Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283
  4. BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365
  5. Burgess A, 2012, APPL CLIN TRIALS
  6. Caldwell PHY, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000368
  7. Canale SD, 2012, ACAD MED, V87, P1243, DOI 10.1097/ACM.0B013E3182628FBF
  8. Denicoff Andrea M, 2013, J Oncol Pract, V9, P267, DOI 10.1200/JOP.2013.001119
  9. Easley J, 2016, CAN FAM PHYSICIAN, V62, P821
  10. Elwyn G, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5146
  11. Hartzband P, 2009, NEW ENGL J MED, V361, P554, DOI 10.1056/NEJMp0904813
  12. Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627
  13. Hui D, 2012, CANCER, V119, P1098
  14. Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1
  15. Levin J, 2006, CHOICE UNCERTAINTY L
  16. Lopes RT, 2015, INT J CLIN HLTH PSYC, V15, P76, DOI 10.1016/j.ijchp.2014.11.001
  17. Malakoff D, 2008, SCIENCE, V322, P210, DOI 10.1126/science.322.5899.210
  18. Mano Max S, 2010, Rare Tumors, V2, pe49, DOI 10.4081/rt.2010.e49
  19. Mathibe LJ, 2007, CONTEMP CLIN TRIALS, V28, P340, DOI 10.1016/j.cct.2007.03.006
  20. Meropol Neal J, 2007, J Natl Compr Canc Netw, V5, P655
  21. Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9
  22. Muluneh B, 2016, J ONCOL PHARM PRACT, V28
  23. Neumann M, 2007, PATIENT EDUC COUNS, V69, P63, DOI 10.1016/j.pec.2007.07.003
  24. Petrova M, 2006, BRIT J GEN PRACT, V56, P703
  25. Renzi C, 2016, CRIT REV ONCOL HEMAT, V99, P134, DOI 10.1016/j.critrevonc.2015.12.010
  26. Rios Izabel Cristina, 2009, Rev. bras. educ. med., V33, P253, DOI 10.1590/S0100-55022009000200013
  27. Robins L, 2011, PATIENT EDUC COUNS, V83, P73, DOI 10.1016/j.pec.2010.05.004
  28. Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91
  29. Sheffield, 2012, BBC NEWS
  30. Shiau SJ, 2008, KAOHSIUNG J MED SCI, V24, P367, DOI 10.1016/S1607-551X(08)70134-7
  31. Stacey D, 2014, COCHRANE DB SYST REV, V10
  32. Tarrant C, 2008, BRIT J GEN PRACT, V58, P780, DOI 10.3399/bjgp08X342615
  33. Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360
  34. Truong TH, 2011, CLIN TRIALS, V8, P616, DOI 10.1177/1740774511414444
  35. Watson Jean, 2003, Nurs Adm Q, V27, P197